Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
This is where clarity matters
Phase 2 data showed mean weight loss of up to 24.2% at 48 weeks, which, if confirmed in phase 3 trials, would surpass both CagriSema and tirzepatide
The moves followed termination of a preliminary agreement by an undisclosed partner global rights giving it global rights to MAT2203, a potential oral broad-spectrum treatment for invasive deadly fungal infections
No weight plateau reached at 40 weeks
Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues
Most people see gradual changes: a subtle glow within ~2 weeks, more even texture by 34 weeks, fading of dark spots over 13 months, and clearer brightening by 36 months in those who respond
US$ 29.23
US$ 25.07
US$ 25.05
US$ 21.62
US$ 25.79
US$ 28.54
US$ 23.98
US$ 28.55
